Personalized care is top of mind when treating prostate cancer.
The multi-disciplinary team in the Urologic Oncology Program includes surgeons, medical oncologists, radiation oncologists, pathologists, researchers and more to properly diagnose and treat your prostate cancer. We are home to a world-renowned urologist who is an expert in minimally invasive laparoscopic and robotic-assisted cancer surgery.
We continue studying the prostate in order to better diagnose and treat prostate cancer, and perhaps prevent it altogether. Timothy G. Wilson, M.D., professor and chair of Urology at the John Wayne Cancer Institute at Providence Saint John’s, leads the charge in research studies.
What Causes Prostate Cancer?
Is Prostate Cancer Deadly?
Does Prostate Cancer Strike a Certain Demographic?
What Are Prostate Cancer Symptoms?
What Is Significant About Prostate Cancer Screenings?
For Slow Growing Prostate Cancer, What Approach Is Taken For Treatment?
What Are The Benefits of Robotic Assisted Surgery For Prostate Cancer?
What Are Common Myths or Concerns You Hear From Your Patients?
Is It True That Grilled Meats Are Linked In Prostate Cancer?
How Often Should I Get Screened If There Is No Family History?
What Advances In Prostate Cancer Treatment or Prevention Do You See In The Future?
How Prostate Cancer is Diagnosed
In order to reach a diagnosis for prostate cancer, we take a thorough medical history and conduct a physical examination to be as accurate as possible. We’ll ask questions, make note of any symptoms you may have experienced and include any other pertinent information.
The following tests may be used to diagnose prostate cancer or to find out if it has spread:
- Digital rectal exam: Your urologic oncologist will determine if there are any bumps or hard areas on the prostate that might be cancer.
- PSA blood test: The prostate-specific antigen blood test is one of the first tests done in men who have symptoms of prostate cancer. Men with a PSA level between 4 and 10 have about a 1 in 4 chance of having prostate cancer. If the PSA is above 10, the chance of having prostate cancer is more than 50 percent.
- Biopsy: Your urologic oncologist inserts a thin needle to remove a sample of tissue from the prostate. A pathologist examines the tissue. If a tumor is found, the pathologist grades the cancer cells and gives them a Gleason score. These scores range from 2 to 10. A tumor with higher grade tends to grow faster and is more likely to spread.
Targeted MRI/Ultrasound Fusion Biopsy
We offer a powerful MR solution for analysis, planning and targeted biopsy of the prostate. This complete clinical MR solution for the prostate consists of DynaCAD for Prostate and the UroNav fusion biopsy system – a comprehensive solution which offers a cutting edge imaging option for many patients with elevated and/or rising PSA levels.
Targeted MR/ultrasound biopsy is poised to become the new standard in prostate care. UroNav fuses pre-biopsy MR images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions.
The fusion of the MR and ultrasound images uses electromagnetic tracking, similar to your car’s GPS system; a tiny tracking sensor attached to the trans-rectal ultrasound probe generates a small, localized electromagnetic field that helps determine the location and orientation of the biopsy device. A sophisticated algorithm maintains the fusion of MR and ultrasound images, even when the patient moves.